All Pharma News
FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic

FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic
CNBC
01 May 2024
Share Share
Covis Announces Completion of Announced Financial Recapitalization Transaction

Covis Announces Completion of Announced Financial Recapitalization Transaction
GLOBENEWSWIRE
01 Jun 2023
Share Share
Covis Statement on FDA Decision to Withdraw Approval of Makena®

Covis Statement on FDA Decision to Withdraw Approval of Makena®
GLOBENEWSWIRE
07 Apr 2023
Share Share
US FDA withdraws approval for Covis Pharma`s preterm birth prevention drug

US FDA withdraws approval for Covis Pharma`s preterm birth prevention drug
REUTERS
07 Apr 2023
Share Share
Covis Announces Signing of Support Agreements With Lenders and Equity Sponsors

Covis Announces Signing of Support Agreements With Lenders and Equity Sponsors
GLOBENEWSWIRE
03 Apr 2023
Share Share
Controversial drug for preterm birth to be withdrawn, maker says

Controversial drug for preterm birth to be withdrawn, maker says
BIOPHARMADIVE
09 Mar 2023
Share Share
Covis Responds to Presiding Officer Report Summarizing FDA Hearing

Covis Responds to Presiding Officer Report Summarizing FDA Hearing
GLOBENEWSWIRE
07 Mar 2023
Share Share
Covis Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial

Covis Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial
GLOBENEWSWIRE
25 Oct 2022
Share Share
An FDA advisory committee voted to pull Covis` drug from market

An FDA advisory committee voted to pull Covis` drug from market
Fraiser Kansteiner FIERCEPHARMA
20 Oct 2022
Share Share
FDA staffers urge withdrawal of Covis` Makena

FDA staffers urge withdrawal of Covis` Makena
Fraiser Kansteiner FIERCEPHARMA
18 Oct 2022
Share Share